Distinct molecular phenotypes of direct vs indirect ARDS in single-center and multicenter studies.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Chest

• Publication date

  2014-12-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/chest.14-2454PMID 26033126PMCID PMC4451708
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Circulating Glycosaminoglycan Signature of Respiratory Failure in Critically Ill Adults*

  2014cited by this paper
• IL1RN coding variant is associated with lower risk of acute respiratory distress syndrome and increased plasma IL-1 receptor antagonist.

  2013cited by this paper
• Biomarkers of lung epithelial injury and inflammation distinguish severe sepsis patients with acute respiratory distress syndrome

  2013cited by this paper
• Clinical and epidemiologic phenotypes of childhood asthma.

  2013cited by this paper
• Acute Respiratory Distress Syndrome The Berlin Definition

  2012cited by this paper
• Plasma angiopoietin-2 in clinical acute lung injury: Prognostic and pathogenetic significance*

  2012cited by this paper
• Asthma phenotypes: the evolution from clinical to molecular approaches

  2012cited by this paper
• Lebrikizumab treatment in adults with asthma.

  2011cited by this paper
• Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study

  2011cited by this paper
• Randomized, placebo-controlled clinical trial of an aerosolized β₂-agonist for treatment of acute lung injury.

  2011cited by this paper
• Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury.

  2010cited by this paper
• Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.

  2009cited by this paper
• Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.

  2009cited by this paper
• Elevated levels of the receptor for advanced glycation end products, a marker of alveolar epithelial type I cell injury, predict impaired alveolar fluid clearance in isolated perfused human lungs.

  2009cited by this paper
• Soluble intercellular adhesion molecule-1 and clinical outcomes in patients with acute lung injury

  2009cited by this paper
• Plasma receptor for advanced glycation end products and clinical outcomes in acute lung injury

  2008cited by this paper
• Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome

  2007cited by this paper
• Comparison of the SpO2/FIO2 ratio and the PaO2/FIO2 ratio in patients with acute lung injury or ARDS.

  2007cited by this paper
• Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury.

  2006cited by this paper
• Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome*

  2006cited by this paper
• Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury.

  2006cited by this paper
• Comparison of two fluid-management strategies in acute lung injury.

  2006cited by this paper
• Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury*

  2005cited by this paper
• Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury

  2005cited by this paper
• Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses.

  2005cited by this paper
• Elevation of KL-6, a lung epithelial cell marker, in plasma and epithelial lining fluid in acute respiratory distress syndrome.

  2004cited by this paper
• Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury.

  2004cited by this paper
• 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

  2003cited by this paper
• Pulmonary and extrapulmonary acute respiratory distress syndrome are different

  2003cited by this paper
• 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference

  2003cited by this paper
• Protein C and thrombomodulin in human acute lung injury.

  2003cited by this paper
• Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury

  2003cited by this paper
• Keratinocyte and hepatocyte growth factors in the lung: roles in lung development, inflammation, and repair.

  2002cited by this paper
• von Willebrand factor antigen is an independent marker of poor outcome in patients with early acute lung injury

  2001cited by this paper
• Efficacy of low tidal volume ventilation in patients with different clinical risk factors for acute lung injury and the acute respiratory distress syndrome.

  2001cited by this paper
• Influence of direct and indirect etiology on acute outcome and 6-month functional recovery in acute respiratory distress syndrome.

  2001cited by this paper
• The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses.

  2001cited by this paper
• The acute respiratory distress syndrome.

  2000cited by this paper
• Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease. Different syndromes?

  1998cited by this paper
• The acute respiratory distress syndrome.

  1996cited by this paper
• The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

  1994cited by this paper

• Burden and outcomes of pediatric acute respiratory distress syndrome among children with sepsis: a cohort study.

  2026cites this paper
• Elevated serum peroxiredoxin 1 is a biomarker of multiorgan failure in ARDS

  2026cites this paper
• Overexpression of IL-8 augments the susceptibility to a hyperinflammatory phenotype in pediatric acute respiratory distress syndrome and correlates with adverse outcomes: a retrospective two-center study conducted in northwest China.

  2026cites this paper
• Careful ventilation in acute respiratory distress syndrome: the protocol of the CAVIARDS international multicentre randomised basket trial

  2026cites this paper
• Identifying a unique signature of sepsis in patients with pre-existing cirrhosis

  2025cites this paper
• The effect of therapeutic plasma exchange on the inflammatory response in septic shock: a secondary analysis of the EXCHANGE-1 trial

  2025cites this paper
• Dual Roles of Hypoxia-Inducible Factor 1 in Acute Lung Injury: Tissue-Specific Mechanisms and Therapeutic Modulation

  2025cites this paper
• Plasma proteomic profiles correlate with organ dysfunction in COVID‐19 ARDS

  2025cites this paper
• Pro‐ and Anti‐Inflammatory Responses and Clinical Outcomes in Critically Ill Patients With Endotheliopathy: A Cohort Study

  2025cites this paper
• Glycocalyx shedding as a clinical biomarker in critical illness.

  2025cites this paper
• Interleukin-6-to-lymphocyte count ratio in the prognosis of moderate-to-severe acute respiratory distress syndrome supported by venovenous extracorporeal membrane oxygenation: a single-center retrospective study

  2025cites this paper
• Prognostic Significance of Serum Mrp 8/14 in Acute Respiratory Distress Syndrome Induced by Pulmonary and Extrapulmonary Sepsis: A Retrospective Controlled Study.

  2025cites this paper
• Construction and Validation of a Risk Assessment Model for Sepsis-Associated Acute Lung Injury in Patients With Sepsis in the Intensive Care Unit

  2025cites this paper
• Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies

  2025cites this paper
• N-Acetylcysteine in the Treatment of Acute Lung Injury: Perspectives and Limitations

  2025cites this paper
• Pro-Reparative Effects of KvLQT1 Potassium Channel Activation in a Mouse Model of Acute Lung Injury Induced by Bleomycin

  2025cites this paper
• Acute respiratory distress syndrome (ARDS): from mechanistic insights to therapeutic strategies

  2025cites this paper
• Inflammation severity, rather than respiratory failure, is strongly associated with mortality of ARDS patients in high-altitude ICUs

  2025cites this paper
• The utility of angiopoietin-2 and blood cell-derived biomarker indices in differentiating rapidly improving acute respiratory distress syndrome (RIARDS) phenotype from persistent-ARDS: a prospective observational study

  2025cites this paper
• Gas-phase fractionation DDA promotes in-depth DIA phosphoproteome analysis

  2025cites this paper
• Unveiling the Molecular Mechanisms of Hemorrhagic Shock and Acute Lung Injury: An Integrative RNA-Seq and Network Analysis.

  2025cites this paper
• The Impact of Inflammatory Biomarker Subphenotypes on Acute Respiratory Distress Syndrome Prognosis: A Systematic Review and Meta-analysis

  2025cites this paper
• The significance and role of the receptor and inflammatory factors in acute respiratory distress syndrome

  2025cites this paper
• Elastance May Determine the Neuromuscular Blockade Effect on Mortality in Acute Respiratory Distress Syndrome.

  2025cites this paper
• Targeting PANoptosis: a promising therapeutic strategy for ALI/ARDS

  2025cites this paper
• Clinical management of sepsis-associated acute respiratory distress syndrome: current evidence and future directions

  2025cites this paper
• The Lancet Child & Adolescent Health Commission on the future of neonatology.

  2025cites this paper
• Exploring trajectories of acute kidney injury in the intensive care unit: a population-based cohort study

  2025cites this paper
• Characteristics, Triggers, Treatments, and Experimental Models of Neonatal Acute Respiratory Distress Syndrome.

  2025cites this paper
• Defining and subphenotyping ARDS: insights from an international Delphi expert panel.

  2025cites this paper
• Acute lung injury induced by traumatic hemorrhagic shock: pathogenesis, biomarkers and therapeutic perspectives.

  2025cites this paper
• Assessing the impact of gut microbiota and metabolic products on acute lung injury following intestinal ischemia-reperfusion injury: harmful or helpful?

  2024cites this paper
• COVID-19 Lung Injury: Unique and Familiar Aspects of Pathophysiology

  2024cites this paper
• CIRCULATING HEPARAN SULFATE PROFILES IN PEDIATRIC ACUTE RESPIRATORY DISTRESS SYNDROME

  2024cites this paper
• Comparative analysis of compartment-specific immunothrombotic biomarker profiles in bronchoalveolar lavage fluid and serum of patients with pneumonia-related acute respiratory distress syndrome: A preliminary cross-sectional study

  2024cites this paper
• Future Directions in Therapies for Acute Respiratory Distress Syndrome.

  2024cites this paper
• Precision Medicine in Acute Respiratory Distress Syndrome: Progress, Challenges, and the Road ahead.

  2024cites this paper
• Modeling lung endothelial dysfunction in sepsis‐associated ARDS using a microphysiological system

  2024cites this paper
• What do we know about micronutrients in critically ill patients? A narrative review

  2024cites this paper
• Endotyping in ARDS: one step forward in precision medicine

  2024cites this paper
• Inhalable spray-dried porous microparticles containing dehydroandrographolide succinate phospholipid complex capable of improving and prolonging pulmonary anti-inflammatory efficacy in mice

  2024cites this paper
• Rapidly improving ARDS differs clinically and biologically from persistent ARDS

  2024cites this paper
• Longitudinal transcriptomic analysis reveals persistent enrichment of iron homeostasis and erythrocyte function pathways in severe COVID-19 ARDS

  2024cites this paper
• Unveiling the Potential of Sulfur-Containing Gas Signaling Molecules in Acute Lung Injury: A Promising Therapeutic Avenue

  2024cites this paper
• Metabolic phenotypes and vitamin D response in the critically ill: A metabolomic cohort study.

  2024cites this paper
• The Thyroid Hormone Analog GC‐1 Mitigates Acute Lung Injury by Inhibiting M1 Macrophage Polarization

  2024cites this paper
• Differential changes in expression of inflammatory mRNA and protein after oleic acid-induced acute lung injury

  2024cites this paper
• Potential biomarkers used for risk estimation of pediatric sepsis-associated organ dysfunction and immune dysregulation

  2024cites this paper
• RespBERT: A Multi-Site Validation of a Natural Language Processing Algorithm, of Radiology Notes to Identify Acute Respiratory Distress Syndrome (ARDS)

  2024cites this paper
• Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS)

  2024cites this paper
• Circulating Biomarkers of Endothelial Dysfunction Associated With Ventilatory Ratio and Mortality in ARDS Resulting From SARS-CoV-2 Infection Treated With Antiinflammatory Therapies

  2024influential citation
• Advances and Applications of Lung Organoids in the Research on Acute Respiratory Distress Syndrome (ARDS)

  2024cites this paper
• Evaluation of interleukin‐1 and interleukin‐6 receptor antagonists in a murine model of acute lung injury

  2024cites this paper
• Metabolic signatures of acute respiratory distress syndrome: COVID VS non-COVID.

  2024cites this paper
• Inflammatory and tissue injury marker dynamics in pediatric acute respiratory distress syndrome

  2024cites this paper
• Translational medicine for acute lung injury

  2024cites this paper
• Heterogeneity, Bayesian thinking, and phenotyping in critical care: A primer.

  2024cites this paper
• Prone positioning does not improve outcomes of intubated patients with pneumocystis pneumonia and moderate–severe acute respiratory distress syndrome: a single-center, retrospective, observational, cohort study

  2024cites this paper
• Effect of a driving pressure-limiting strategy for patients with acute respiratory distress syndrome secondary to community-acquired pneumonia: the STAMINA randomised clinical trial.

  2024cites this paper
• Foxq1 Promotes Alveolar Epithelial Cell Death through Tle1-mediated Inhibition of the NFκB Signaling Pathway.

  2024cites this paper
• Corticosteroids treatment for pediatric acute respiratory syndrome

  2023cites this paper
• A Targeted Analysis of Serial Cytokine Measures and Nonpulmonary Organ System Failure in Children With Acute Respiratory Failure: Individual Measures and Trajectories Over Time

  2023cites this paper
• Sustained Perturbation of Metabolism and Metabolic Subphenotypes Are Associated With Mortality and Protein Markers of the Host Response

  2023cites this paper
• Pregnancy and Severe ARDS with COVID-19: Epidemiology, Diagnosis, Outcomes and Treatment

  2023cites this paper
• A Systematic Review and Meta-Analysis of Independent Predictors for Acute Respiratory Distress Syndrome in Patients Presenting With Sepsis

  2023cites this paper
• Integrative proteomic profiling of lung tissues and blood in acute respiratory distress syndrome

  2023cites this paper
• Plasma bioactive adrenomedullin on intensive care unit admission is associated with acute respiratory distress syndrome: an observational study

  2023cites this paper
• Cardiovascular Subphenotypes in ARDS: Diagnostic and Therapeutic Implications and Overlap with Other ARDS Subphenotypes

  2023cites this paper
• Immunocompromised Children With Acute Respiratory Distress Syndrome Possess a Distinct Circulating Inflammatory Profile

  2023cites this paper
• Sepsis-related pediatric acute respiratory distress syndrome: A multicenter prospective cohort study

  2023cites this paper
• Advancing Precision Medicine for the Diagnosis and Treatment of Acute Respiratory Distress Syndrome

  2023cites this paper
• Circulating protein and lipid markers of early sepsis diagnosis and prognosis: a scoping review.

  2023cites this paper
• Endothelial dysfunction triggers acute respiratory distress syndrome in patients with sepsis: a narrative review

  2023cites this paper
• Puntaje APP (Age, PaO2/FiO2, Plateau) predice mortalidad en choque séptico de etiología pulmonar

  2023cites this paper
• Advances of presepsin in sepsis-associated ARDS.

  2023cites this paper
• Acute respiratory distress syndrome heterogeneity and the septic ARDS subgroup

  2023cites this paper
• Expression and significance of serum KL-6 in patients with acute respiratory distress syndrome

  2023cites this paper
• Circulating Surfactant Protein D: A Biomarker for Acute Lung Injury?

  2023cites this paper
• Modeling Sepsis-Associated ARDS Using a Lung Endothelial Microphysiological System

  2023influential citation
• Inflammatory subphenotypes in patients at risk of ARDS: evidence from the LIPS-A trial

  2023cites this paper
• Subphenotypes of Acute Respiratory Distress Syndrome: Advancing Towards Precision Medicine

  2023cites this paper
• Estimating the attributable fraction of mortality from acute respiratory distress syndrome to inform enrichment in future randomised clinical trials

  2023cites this paper
• Novel approaches that promote lung endothelial and epithelial repair and anti pro inflammatory cytokines could be a future promising agent in the management of ARDS

  2023cites this paper
• EVALUATION OF CYFRA 21-1, ANGIOPOETIN-2, PENTRAXIN-3, SRAGE, IL-6, AND IL-10 IN POLYTRAUMATIZED PATIENTS WITH CONCOMITANT THORACIC TRAUMA—HELPFUL MARKERS TO PREDICT PNEUMONIA?

  2023cites this paper
• Machine learning-based COVID-19 acute respiratory distress syndrome phenotyping and clinical outcomes: A systematic review

  2023cites this paper
• Inflammatory and coagulant responses after acute respiratory failure in children of different body habitus

  2023cites this paper
• Circulatory HMGB1 is an early predictive and prognostic biomarker of ARDS and mortality in a swine model of polytrauma

  2023cites this paper
• Efficacy of surfactant therapy of ARDS induced by hydrochloric acid aspiration followed by ventilator-induced lung injury - an animal study.

  2022cites this paper
• Serum Markers of ARDS: How Can We Know the Severity and Prognosis from the Serum Markers?

  2022cites this paper
• Differentiating septic children with and without acute respiratory distress syndrome using proteomics.

  2022cites this paper
• Pulmonary Fibrosis as a Result of Acute Lung Inflammation: Molecular Mechanisms, Relevant In Vivo Models, Prognostic and Therapeutic Approaches

  2022cites this paper
• Integrating biology into clinical trial design

  2022cites this paper
• Towards a biological definition of ARDS: are treatable traits the solution?

  2022cites this paper
• Monitoring of the Forgotten Immune System during Critical Illness—A Narrative Review

  2022cites this paper
• Strategies to minimize heterogeneity and optimize clinical trials in Acute Respiratory Distress Syndrome (ARDS): Insights from mathematical modelling

  2022cites this paper
• Refining the Pediatric Multiple Organ Dysfunction Syndrome.

  2022cites this paper
• 2021 Acute Respiratory Distress Syndrome Update, With Coronavirus Disease 2019 Focus

  2022cites this paper
• Glycyrrhizin mitigates acute lung injury by inhibiting the NLRP3 inflammasome in vitro and in vivo.

  2022cites this paper
• Awake prone positioning in nonintubated spontaneous breathing ICU patients with acute hypoxemic respiratory failure (PRONELIFE)—protocol for a randomized clinical trial

  2022cites this paper
• Serial Measurements of Protein Biomarkers in Sepsis-Induced Acute Respiratory Distress Syndrome

  2022cites this paper